← Back to directory
A
ARCH Venture Partners
🇬🇧 UK-activeSeed VC·Chicago, United States·5 partners Ari Nowacek +4
stages Seed, Series A; cheque €4.6M - €46M.
Cheque range (GBP)
£4.6M – £46M
Typical: €4.6M - €46M
Last cheque
3mo ago
● actively deploying
Rounds (12mo)
5
1 in last 90d
Tracked portfolio
5
since 2026
Recent investments
5 tracked rounds via funding databases| Company | Amount | When |
|---|---|---|
| Moleculent ↗ Decodes cellular networks to advance human health | $20M | 3mo ago |
| Lightcast ↗ Develops functional single-cell analysis tools and platforms for life science research | $27M | 3mo ago |
| Mirador Therapeutics ↗ Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases | $250M | 6mo ago |
| Parabilis Medicines ↗ Develops medicines targeting historically undruggable protein targets in cancer | $305M | 7mo ago |
| Vizgen ↗ Builds technologies for spatial biology and multi-omics innovation | $48M | 7mo ago |
Stages backed
Series B1 · 33%
Series F1 · 33%
Series A1 · 33%
Markets backed
Sectors & focus
Business models
Deep tech, Hardware, SaaS
Frequent co-investors
From tracked deal dataWant a match-quality estimate?
Score your pitch and we'll tell you if ARCH Venture Partners matches your stage, sector, and cheque — before you ever email them.
Score my pitch →For Ari & team at ARCH Venture Partners
This profile isn't claimed yet.
Claim it to correct your mandate, fix anything that's wrong, and start receiving UK founders who actually fit what you back.
Claim this profile →